Illumina ended March with $1.237 billion in cash and investments, a current ratio of nearly 2, and long-term debt of $1.49 billion. Illumina continues its NovaSeq X rollout. The company placed 60 ...

Illumina's share price has declined by 83.61% between August 09, 2021, and March 20, 2025. The first valuation model suggests that Illumina is undervalued by 24.46%.

Illumina’s stock closed Wednesday at $84.20 per share, down 32 cents. Its stock value is down about 36% year to date, as the company has also been trying to rebound from its failed $7.1 ...

Illumina, Inc. (NASDAQ: ... Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future.

Illumina, Inc. (NASDAQ: ILMN) today announced a new spatial technology program that will empower researchers to map complex tissues and understand cellular behavior at an unprecedented scale.

SAN FRANCISCO—Nvidia will partner with Illumina to apply genomics and AI technologies to analyze and interpret multi-omic data in drug discovery, clinical research, and human health, the ...

To kick off the project, Regeneron made an upfront strategic investment of $119.5 million into Truveta, while Illumina chipped in $20 million as part of a series C financing.

In 2023, Illumina opened a new office and state-of-the-art genomics lab–known as an Illumina Solutions Center–in Bengaluru. The facility provides training and education and features a fully equipped ...

Bengaluru (Karnataka) [India], December 6: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today celebrated the opening of a global capability center ...

We are keeping our fair value estimate on Illumina at $144 per share. In a sequencing industry that is expected to grow in the low double digits compounded annually during the next decade, we ...

UCL Genomics is a collaborative research facility with expertise in state-of-the-art genomic technologies, project design and data analysis. Operational for over 20 years, this cost recovery, ...